Amycretin is a long-acting co-agonist of the GLP-1 receptor and amylin receptor
As everyones skin reacts differently, the total number of shots differs
Mounjaro (tirzepatide) is a once-weekly subcutaneous injection that activates two gut hormone receptors at once, GIP and GLP-1, to suppress appetite, slow gastric emptying, improve insulin sensitivity, and increase energy use
In 2026, that approach isn't just unhelpful - it's a disservice
Yes, several GLP-1s have been in short supply for months, though some appear to be back in stock
Ortiz carefully assesses each patient to ensure they are a suitable candidate for tirzepatide injections